acquired
Stage
2
Investors
About
Biolux develops a novel light therapy device designed to treat oral mucositis, a severe side effect experienced by cancer patients during therapy.
Explore Biolux's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.